SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-040979
Filing Date
2016-11-03
Accepted
2016-11-03 15:11:30
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insy20160818_10q.htm 10-Q 1338968
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11426
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 11382
4 EXHIBIT 32 ex32.htm EX-32 9686
  Complete submission text file 0001437749-16-040979.txt   5682679

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS insy-20160930.xml EX-101.INS 1335431
6 EXHIBIT 101.SCH insy-20160930.xsd EX-101.SCH 42407
7 EXHIBIT 101.CAL insy-20160930_cal.xml EX-101.CAL 39695
8 EXHIBIT 101.DEF insy-20160930_def.xml EX-101.DEF 295078
9 EXHIBIT 101.LAB insy-20160930_lab.xml EX-101.LAB 254459
10 EXHIBIT 101.PRE insy-20160930_pre.xml EX-101.PRE 317728
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 161971298
SIC: 2834 Pharmaceutical Preparations